ARHGAP42P5

Across TCGA pan-cancer cohorts, ARHGAP42P5 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated ARHGAP42P5 data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher ARHGAP42P5 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated ARHGAP42P5 expression acts as an unfavorable survival marker, although some lineages such as UCS show a favorable association.

READ, KICH, and UCEC are the cancer types where ARHGAP42P5 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	DFS	Tertile	All	0.082	0.799	<.001	63	view →
KICH	DFS	Tertile	All	0.043	0.971	<.001	60	view →
UCEC	DFS	Tertile	All	0.820	0.905	.012	42	view →
CESC	OS	Tertile	II,III,IV	0.170	0.764	<.001	36	view →
STAD	DFS	Quartile	All	0.519	0.749	.004	21	view →
LAML	DFS	Tertile	All	0.222	0.582	.043	18	view →
COAD	DFS	Tertile	II,III,IV	0.620	0.782	.028	18	view →
LUAD	OS	Tertile	IV	0.153	0.714	.012	18	view →
LIHC	DFS	Tertile	All	0.123	0.537	<.001	18	view →
UCS	OS	Tertile	III,IV	1.000	0.301	.047	12	view →
THCA	OS	Tertile	IV	0.520	0.857	.015	12	view →
HNSC	DFS	Tertile	III,IV	0.201	0.514	.020	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

ARHGAP42P5–READ (DFS)

Open the READ breakdown →